You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

NORGESTIMATE AND ETHINYL ESTRADIOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Norgestimate And Ethinyl Estradiol patents expire, and what generic alternatives are available?

Norgestimate And Ethinyl Estradiol is a drug marketed by Amneal Pharms, Glenmark Pharms Ltd, Glenmark Speclt, Lupin Ltd, Lupin Pharms, Mylan, Naari Pte Ltd, Watson Labs, and Xiromed. and is included in seventeen NDAs.

The generic ingredient in NORGESTIMATE AND ETHINYL ESTRADIOL is ethinyl estradiol; norgestimate. There are twenty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestimate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NORGESTIMATE AND ETHINYL ESTRADIOL?
  • What are the global sales for NORGESTIMATE AND ETHINYL ESTRADIOL?
  • What is Average Wholesale Price for NORGESTIMATE AND ETHINYL ESTRADIOL?
Summary for NORGESTIMATE AND ETHINYL ESTRADIOL
Drug patent expirations by year for NORGESTIMATE AND ETHINYL ESTRADIOL
Recent Clinical Trials for NORGESTIMATE AND ETHINYL ESTRADIOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Benha UniversityPhase 2/Phase 3
AmgenPhase 1
Gilead SciencesPhase 1

See all NORGESTIMATE AND ETHINYL ESTRADIOL clinical trials

US Patents and Regulatory Information for NORGESTIMATE AND ETHINYL ESTRADIOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms NORGESTIMATE AND ETHINYL ESTRADIOL ethinyl estradiol; norgestimate TABLET;ORAL-28 203870-001 Nov 12, 2015 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lupin Ltd NORGESTIMATE AND ETHINYL ESTRADIOL ethinyl estradiol; norgestimate TABLET;ORAL-28 205588-001 Apr 26, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glenmark Pharms Ltd NORGESTIMATE AND ETHINYL ESTRADIOL ethinyl estradiol; norgestimate TABLET;ORAL-28 200494-001 Jun 17, 2011 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Naari Pte Ltd NORGESTIMATE AND ETHINYL ESTRADIOL ethinyl estradiol; norgestimate TABLET;ORAL-28 200384-001 Apr 7, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lupin Ltd NORGESTIMATE AND ETHINYL ESTRADIOL ethinyl estradiol; norgestimate TABLET;ORAL-28 205630-001 Oct 27, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Xiromed NORGESTIMATE AND ETHINYL ESTRADIOL ethinyl estradiol; norgestimate TABLET;ORAL-28 202132-001 Sep 9, 2015 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs NORGESTIMATE AND ETHINYL ESTRADIOL ethinyl estradiol; norgestimate TABLET;ORAL-28 076626-001 Aug 17, 2006 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.